Bifidobacterium infantis 35624: What It Is, Benefits, Dosage, and Sources

Bifidobacterium infantis 35624 is a specific, well-researched strain of probiotic bacteria. It's often referred to by its full name, Bifidobacterium longum subsp. infantis 35624, reflecting its classification within the broader Bifidobacterium longum species. This particular strain has garnered attention for its potential role in gut health, distinct from other Bifidobacterium strains or probiotics in general. Understanding what sets it apart, its purported benefits, and how it's typically used can help clarify its place in digestive wellness.

Understanding Bifidobacterium infantis 35624's Role in Gut Health

The human gut microbiome is a complex ecosystem of trillions of microorganisms, including bacteria, fungi, and viruses. Bifidobacterium is one of the most common genera of beneficial bacteria found in the gastrointestinal tract, especially prominent in infants. Within this genus, Bifidobacterium infantis 35624 (often abbreviated as B. infantis 35624) is a specific strain identified and studied for its unique characteristics.

What makes strain 35624 distinct isn't just its name, but its documented ability to interact with the host's intestinal environment. This interaction is thought to involve modulating certain physiological processes within the gut. Unlike many generic probiotics, which might offer broad support, B. infantis 35624 has been investigated for specific actions.

For instance, this strain has been observed to influence the gut's immune responses. The gut lining contains a significant portion of the body's immune cells, and the balance of gut bacteria can affect how these cells behave. B. infantis 35624 is thought to contribute to a balanced immune response within the digestive system, rather than stimulating an overactive or underactive one. This can have practical implications for individuals experiencing digestive discomfort related to internal gut processes.

Another key aspect is its potential to interact with the gut-brain axis. This bidirectional communication system links the central nervous system with the enteric nervous system of the gut. The bacteria in the gut can produce various compounds that may influence this axis, potentially affecting mood, stress response, and even pain perception. Research into B. infantis 35624 has explored its capacity to contribute to this communication, offering a potential pathway for digestive comfort.

It's important to differentiate B. infantis 35624 from other Bifidobacterium infantis strains. The "35624" designation is crucial because probiotic effects are often strain-specific. What one strain of Bifidobacterium infantis does, another might not, or might do differently. This specificity is why clinical studies often focus on a particular strain rather than a broad species. When considering a probiotic, the specific strain matters as much as, if not more than, the genus and species.

Benefits Attributed to Bifidobacterium infantis 35624

The potential Bifidobacterium infantis 35624 benefits primarily revolve around digestive comfort and gut health. Much of the research has focused on its role in addressing symptoms associated with certain common gastrointestinal conditions.

One of the most frequently discussed benefits is its potential to help manage symptoms of Irritable Bowel Syndrome (IBS). IBS is a functional gastrointestinal disorder characterized by abdominal pain, bloating, gas, and altered bowel habits (constipation, diarrhea, or both). Studies involving B. infantis 35624 have explored its ability to reduce these symptoms, particularly abdominal pain and discomfort, and to help normalize bowel function in some individuals with IBS. The mechanism is thought to involve its modulatory effects on gut inflammation and its interaction with the gut-brain axis, potentially easing visceral hypersensitivity (increased pain perception in the gut).

Beyond IBS, B. infantis 35624 has been investigated for its broader impact on gut health, including its potential to support a balanced gut microbiome. A healthy microbiome is diverse and populated with beneficial bacteria, which can help prevent the overgrowth of less desirable microbes. While B. infantis 35624 doesn't necessarily "colonize" the gut long-term in the way some resident bacteria do, its transient presence can exert beneficial effects, potentially by producing short-chain fatty acids or by influencing the local immune environment.

The strain's ability to modulate inflammatory markers in the gut has also been a subject of interest. Chronic, low-grade inflammation in the gut is sometimes associated with digestive discomfort. By potentially influencing immune pathways, B. infantis 35624 may contribute to a more balanced inflammatory state within the intestinal lining.

It's worth noting that while research is promising, individual responses to probiotics can vary. Factors such as diet, lifestyle, existing gut conditions, and the composition of one's unique microbiome can all influence the effectiveness of a Bifidobacterium infantis 35624 supplement.

How Bifidobacterium infantis 35624 Supports the Digestive System

The digestive system's health is intrinsically linked to the balance of its microbial inhabitants. Bifidobacterium infantis 35624 supports this system through several proposed mechanisms, primarily by interacting with the gut environment and influencing host responses.

One key mechanism involves its potential to strengthen the gut barrier. The gut lining acts as a semi-permeable barrier, allowing nutrients to pass into the bloodstream while preventing harmful substances and undigested food particles from entering. A compromised gut barrier, sometimes referred to as "leaky gut," is associated with various digestive issues. While research is ongoing, some studies suggest that certain probiotics, including B. infantis 35624, may help support the integrity of this barrier, potentially by influencing the tight junctions between intestinal cells.

Another way it contributes is through its interaction with the immune system located in the gut-associated lymphoid tissue (GALT). The GALT is a significant component of the body's immune defense. B. infantis 35624 has been shown to modulate the production of certain cytokines, which are signaling molecules that regulate immune and inflammatory responses. By influencing these signals, the strain may help maintain a balanced immune response in the gut, which is crucial for overall digestive comfort and health. For example, some research indicates a reduction in pro-inflammatory markers and an increase in anti-inflammatory markers in individuals consuming this strain.

Furthermore, B. infantis 35624 may contribute to the metabolic activities within the gut. Like other beneficial bacteria, it can ferment dietary fibers and prebiotics that are not digested by human enzymes. This fermentation process produces short-chain fatty acids (SCFAs) like butyrate, propionate, and acetate. SCFAs serve as an energy source for colonocytes (cells lining the colon) and are involved in various physiological processes, including immune regulation and gut barrier function. While B. infantis 35624's primary role might not be SCFA production compared to some other strains, its contribution can still be part of a broader beneficial microbial community.

The interaction with the nervous system, specifically the enteric nervous system (ENS), which controls gut function, is also relevant. The gut-brain axis is a complex communication network, and changes in the gut microbiome can impact its signaling. B. infantis 35624 has been explored for its potential to positively influence this axis, which could, in turn, affect gut motility, sensation, and overall digestive comfort. For individuals experiencing functional gut disorders, this aspect of probiotic action is particularly pertinent.

Bifidobacterium infantis 35624 vs. Other Bifidobacterium Strains

Not all Bifidobacterium strains are interchangeable. Bifidobacterium infantis is a species, and it contains many different strains. Bifidobacterium infantis 35624 is a specific, patented strain that has been extensively studied.

To illustrate the distinction, consider a comparison:

The key takeaway is that when a product claims benefits from "Bifidobacterium infantis", without the specific strain number (like 35624), those benefits may not directly translate to the research conducted on B. infantis 35624. The effects are strain-specific. This is why consumers seeking the benefits associated with B. infantis 35624 should look for products that explicitly list this specific strain.

Efficacy of Encapsulated Bifidobacterium infantis 35624

The efficacy of any probiotic, including Bifidobacterium infantis 35624, is heavily dependent on its ability to survive the harsh conditions of the gastrointestinal tract and reach the intestines alive. The stomach's acidic environment and the presence of digestive enzymes can degrade probiotic bacteria before they can exert their beneficial effects. This is where encapsulation comes into play.

Encapsulation refers to the process of enclosing probiotic bacteria within a protective matrix. This matrix is designed to shield the bacteria from stomach acid and bile, allowing a greater number of live organisms to reach the lower digestive tract. Different encapsulation technologies exist, ranging from simple coatings to more complex microencapsulation techniques.

For Bifidobacterium infantis 35624, many commercial supplements utilize advanced encapsulation methods to ensure viability. These methods are intended to:

• Protect against gastric acid: The low pH of the stomach is lethal to many bacterial strains. Encapsulation helps maintain a neutral microenvironment around the bacteria, allowing them to pass through the stomach unharmed.
• Resist bile salts: In the small intestine, bile salts can also be detrimental to probiotic survival. Protective coatings can offer resistance to these compounds.
• Deliver live cells: The ultimate goal is to deliver a sufficient number of live, active Colony-Forming Units (CFUs) to the intestines, where they can interact with the host and exert their effects.

When evaluating a Bifidobacterium infantis 35624 supplement, considering the encapsulation method (if specified) and the guaranteed CFU count at the time of expiry, rather than just at the time of manufacture, can be important indicators of product quality and potential efficacy. A product that guarantees a certain number of live cells through its shelf life, often due to effective encapsulation, is more likely to deliver the intended benefits.

Clinical studies on B. infantis 35624 have often utilized products with specific encapsulation technologies, and the reported efficacy in those studies is linked to the successful delivery of viable bacteria. Therefore, choosing a supplement from a reputable manufacturer that details its commitment to probiotic viability is a practical step for consumers.

Bifidobacterium infantis 35624 Dosage and Supplementation

Determining the appropriate Bifidobacterium infantis 35624 dosage is crucial for achieving potential benefits. Unlike some other supplements where more is often assumed to be better, probiotic efficacy is often strain- and dose-dependent.

For Bifidobacterium infantis 35624, many of the clinical studies that have demonstrated benefits for conditions like IBS have used a specific dosage. This typically falls in the range of 1 x 10^7 to 1 x 10^9 Colony-Forming Units (CFUs) per day.

Most commercially available Bifidobacterium infantis 35624 supplements (often sold under specific brand names) provide a dosage within this range, frequently around 1 billion (1 x 10^9) CFUs per capsule. It's generally recommended to follow the specific instructions provided on the product label, as formulations can vary.

When considering a Bifidobacterium infantis 35624 supplement, here are some practical considerations:

• CFU Count: Look for products that clearly state the CFU count per serving, and ideally, that guarantee this count through the product's expiration date.
• Strain Specificity: Ensure the product explicitly lists "35624" or the full name Bifidobacterium longum subsp. infantis 35624. Generic "Bifidobacterium infantis" supplements may not contain this specific, researched strain.
• Storage: Some probiotics require refrigeration to maintain viability, while others are shelf-stable due to advanced encapsulation. Always check the product's storage instructions.
• Timing of Intake: While specific timing might vary by product, many probiotics are recommended to be taken with food or a meal to help buffer stomach acid and improve survival. However, some encapsulated strains are designed to be taken at any time.
• Consistency: Probiotic benefits are generally observed with consistent daily intake over a period of weeks or months, rather than intermittent use.

Regarding Bifidobacterium infantis 35624 side effects, this strain is generally considered safe and well-tolerated by most individuals. When starting any probiotic, some people might experience mild, temporary digestive discomforts such as gas, bloating, or changes in bowel habits. These symptoms usually subside as the body adjusts to the new microbial balance. If symptoms persist or worsen, it's advisable to consult a healthcare professional.

Individuals with compromised immune systems, those with severe underlying medical conditions, or those who have recently undergone surgery should consult a doctor before starting any probiotic supplement, including B. infantis 35624. While rare, there's a theoretical risk of infection in severely immunocompromised individuals.

Sources of Bifidobacterium infantis 35624

Unlike some other beneficial bacteria that are naturally abundant in common fermented foods, Bifidobacterium infantis 35624 is primarily obtained through targeted supplementation. It is not generally found in significant, reliably therapeutic quantities in everyday dietary sources.

Here's a breakdown of its sources:

• Probiotic Supplements: This is the most direct and reliable source. Bifidobacterium infantis 35624 is a proprietary strain, meaning it has been isolated, characterized, and often patented by specific companies. It is typically sold as a single-strain supplement or as a key component in multi-strain probiotic blends where its specific effects are highlighted. When purchasing, look for products that clearly state "Bifidobacterium infantis 35624" on the label. A notable example of a product that features this strain is Align Probiotic.
• Limited Presence in Fermented Foods: While various Bifidobacterium species can be found in some fermented foods like yogurt, kefir, or certain fermented vegetables, it's highly unlikely to encounter the specific strain Bifidobacterium infantis 35624 in these products. The strains present in fermented foods are diverse and depend on the starter cultures used and the fermentation process. If a fermented food does contain B. infantis 35624, it would typically be because it has been specifically added as a fortified ingredient, and this would be clearly indicated on the packaging.
• Breast Milk: Bifidobacterium infantis in general is a predominant species in the gut of breastfed infants, playing a crucial role in their early gut development and immune programming. However, this refers to the species as a whole, not specifically the 35624 strain. The presence and specific strains of B. infantis in breast milk can vary.

For those specifically seeking the researched benefits attributed to Bifidobacterium infantis 35624, a dedicated supplement containing this strain is the most practical and effective approach. Relying on general fermented foods for this specific strain is not a viable strategy.

Frequently Asked Questions

What is the best source of Bifidobacterium infantis?

For Bifidobacterium infantis 35624 specifically, the best source is a probiotic supplement that explicitly lists this strain. While other Bifidobacterium species are found in fermented foods like yogurt and kefir, the 35624 strain is proprietary and typically only available in targeted probiotic products.

Which probiotics contain Bifidobacterium infantis 35624?

Several probiotic supplements contain Bifidobacterium infantis 35624. The most well-known product featuring this specific strain is often marketed under brand names like Align. When looking for a supplement, check the ingredients list to ensure it explicitly states "Bifidobacterium longum subsp. infantis 35624" or "Bifidobacterium infantis 35624."

Should adults take Bifidobacterium infantis?

Adults may consider taking Bifidobacterium infantis 35624, particularly if they are experiencing digestive discomforts such as those associated with Irritable Bowel Syndrome (IBS), including abdominal pain, bloating, and gas. Research on this specific strain suggests potential benefits for these symptoms. However, as with any supplement, it's advisable to consult a healthcare professional to determine if it's appropriate for individual needs and health conditions.

Conclusion

Bifidobacterium infantis 35624 is a specific and well-studied probiotic strain with documented potential to support digestive comfort, particularly for individuals experiencing symptoms of Irritable Bowel Syndrome. Its distinct mechanisms, including modulating gut immune responses and interacting with the gut-brain axis, set it apart from general probiotic offerings. When considering supplementation, the emphasis is on strain specificity, appropriate dosage, and product quality to ensure the delivery of viable bacteria. For those seeking targeted support for digestive wellness, understanding the unique characteristics of B. infantis 35624 can guide informed choices.